Judgment of the Court (First Chamber), 6 December 2012
AstraZeneca AB and AstraZeneca plc v European Commission
Appeal — Competition — Abuse of dominant position — Market in anti-ulcer medicines — Abuse of procedures relating to supplementary protection certificates for medicinal products and of marketing authorisation procedures for medicinal products — Misleading representations — Deregistration of marketing authorisations — Obstacles to the marketing of generic medicinal products and to parallel imports
Case C‑457/10 P
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general)
Links to the texts
|
Curia |
EUR-Lex |
Autres Liens |
Opinion
ECLI:EU:C:2012:293 |
|
|
|
Judgment
ECLI:EU:C:2012:770 |
|
|
|